Increased [qnco]
Recurrent [tmco]
Venous Thromboembolism [patf]
Hormone [horm]
Replacement therapy [topp]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Estrogen [horm, phsu, strd]
Venous Thromboembolism [patf]
Trial [resa]
Observational Study [resa]
Suggest [idcn]
Fold [spco]
Increased [qnco]
Venous Thromboembolism [patf]
Women [popg]
Take [hlca]
Hormone replacement therapy [topp]
Present [qnco]
Study [mnob]
Started [qlco]
Publication [inpr, mnob]
If [qlco]
Hormone replacement therapy [topp]
Altered [ftcn]
Venous Thromboembolism [patf]
High Risk [qlco]
Women [popg]
Study [mnob]
randomized [resa]
DOUBLE BLIND [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
Double [ftcn]
Triangular [cnce]
Sequential [idcn]
Design [acty]
Females [fndg]
Verified [ftcn]
Venous Thromboembolism [patf]
randomized [resa]
mg% [qnco]
Estradiol + norethindrone acetate [horm, phsu, strd]
Plus [qlco]
Tablet [bodm]
Daily [tmco]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
Primary [qlco]
Venous thrombosis, recurrent [fndg]
Deep [spco]
Pulmonary Embolism [dsyn]
Women [popg]
included [ftcn]
Study [mnob]
terminated [idcn]
Based [ftcn]
Circumstantiality [mobd]
Trial [resa]
Eight [qnco]
Women [popg]
Hormone replacement therapy [topp]
Group [idcn]
Woman [popg]
placebo [topp]
Group [idcn]
Venous Thromboembolism [patf]
Venous Thromboembolism [patf]
Hormone replacement therapy [topp]
Group [idcn]
2-3 [resa]
placebo [topp]
Group [idcn]
Hormone replacement therapy [topp]
Group [idcn]
Events [evnt]
Happened [acty]
days [tmco]
Inclusion [qlco]
Sequential [idcn]
Design [acty]
Stop [acty]
Study [mnob]
Indicated [fndg]
Group [idcn]
Suggest [idcn]
Women [popg]
suffered [mobd]
Venous Thromboembolism [patf]
Increased [qnco]
Hormone replacement therapy [topp]
treatment [ftcn]
Group [idcn]
Support [medd]
Epidemiological Studies [resa]
Increased [qnco]
Venous Thromboembolism [patf]
Select [acty]
Female [fndg]
Hormone replacement therapy [topp]
